Close

Acadia Pharma (ACAD) Hits New 52-Week High on Volume Over Key Resistance Level

October 5, 2012 12:47 PM EDT
Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) is showing some unusually strong volume Friday as shares pop to a new annual high.

Currently, about 4.6 million shares have traded compared with the daily average that is just below 1 million.

Causing the increased volume is ACADIA moving above the $2.80 level. That level was largely a resistance point for the pharma in September, which shares were parabolic.

With the exception of a spike higher in April 2011, this is the first time ACADIA has been back above $3 since September 2009.

The stock is currently up 1.5 percent on the session.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Technicals, Trader Talk